Cargando…
Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
Lung cancer is the most common cause of cancer deaths all over the world, in which non-small cell lung cancer (NSCLC) accounts for ~85% of cases. It is well known that microRNAs (miRNAs) play a critical role in various cellular processes, mediating post-transcriptional silencing either by mRNA degra...
Autores principales: | Hou, Jinpao, Meng, Fei, Chan, Lawrence W. C., Cho, William C. S., Wong, S. C. Cesar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093122/ https://www.ncbi.nlm.nih.gov/pubmed/27857721 http://dx.doi.org/10.3389/fgene.2016.00193 |
Ejemplares similares
-
Circulating MicroRNAs in Plasma Decrease in Response to Sarcopenia in the Elderly
por: He, Nana, et al.
Publicado: (2020) -
Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis
por: Cho, William C. S.
Publicado: (2011) -
Editorial: Cancer Diagnostic and Therapeutic Target Identification and Verification Based on the Regulatory Functions of MicroRNAs
por: Chan, Lawrence W. C., et al.
Publicado: (2017) -
Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
por: Yao, Yunjin, et al.
Publicado: (2021) -
Circulating MicroRNAs in Cancer: Potential and Challenge
por: Cui, Mengying, et al.
Publicado: (2019)